It improves diabetic complications and T cell function in patients with COVID-19 by reprogramming dendritic cell metabolism, inducing tolerance, and reducing pro-inflammatory factors such as IL-2 and tumor necrosis factor alpha (76). This evidence concerns the gene IL2 and COVID-19.